Home/Aida Oncology/Ulla Hald Buhl
UH

Ulla Hald Buhl

CEO

Aida Oncology

Therapeutic Areas

Aida Oncology Pipeline

DrugIndicationPhase
OncoTect for Taxanes in Advanced Breast CancerAdvanced Breast CancerClinical Validation
OncoTect for Taxanes in Early-Stage Breast CancerEarly-Stage Breast CancerClinical Validation
AI-driven 113-gene signature for T-AC therapyEarly-Stage Breast Cancer (Neoadjuvant)Clinical Validation